Q-SERA
Q-Sera technology aims to accelerate the clotting of blood to more rapidly produce high quality serum in blood clotting tubes. Q-Sera Pty Ltd uses the coagulant properties of snake venom-derived proteins to develop blood collection tubes that rapidly produce high quality serum. Australian scientists have found a way to use components of snake venom to improve an essential clinical tool which will assist in optimising laboratory efficiency, clinical diagnosis and patient care. The venom of ... some snakes (including the Australian Taipan) has a potent ability to coagulate the blood of mammals including humans and it is this ability which caught the interest of a group of Queensland medical scientists and pathologists. The team isolated the potent clotting proteins and used them to develop superior blood collection tubes.
Q-SERA
Industry:
Health Care Medical Medical Device
Founded:
2012-01-01
Address:
Melbourne, Victoria, Australia
Country:
Australia
Website Url:
http://www.q-sera.com
Total Employee:
11+
Status:
Active
Contact:
+61396570714
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon WordPress Content Delivery Network Google Universal Analytics
Current Employees Featured
Investors List
Stoic VC
Stoic VC investment in Venture Round - Q-Sera
Brandon Capital Partners
Brandon Capital Partners investment in Venture Round - Q-Sera
Uniseed Ventures
Uniseed Ventures investment in Venture Round - Q-Sera
Medical Research Commercialisation Fund (MRCF)
Medical Research Commercialisation Fund (MRCF) investment in Seed Round - Q-Sera
Brandon Capital Partners
Brandon Capital Partners investment in Seed Round - Q-Sera
Official Site Inspections
http://www.q-sera.com
- Host name: 139.59.193.230
- IP address: 139.59.193.230
- Location: Singapore
- Latitude: 1.314
- Longitude: 103.6839
- Timezone: Asia/Singapore
- Postal: 62
